
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1041 | 1041 | 1094 | 1224 | 1793 | 1672 |
Fund Return | 4.13% | 4.13% | 9.44% | 6.97% | 12.39% | 5.28% |
Place in category | 111 | 111 | 132 | 107 | 106 | 91 |
% in Category | 21 | 21 | 32 | 26 | 29 | 35 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CF Canlife Global Equity Fund C Acc | 13.11M | -5.73 | 6.80 | 10.21 | ||
CF Canlife Portfolio V Fund C Acc | 147.09M | 2.87 | 4.78 | 5.61 | ||
CF Canlife North American Fund C Ac | 17.26M | -8.49 | 6.83 | 12.47 | ||
CF Canlife Portfolio III Fund C Acc | 34.37M | 1.71 | 0.80 | 2.73 | ||
CF Canlife Portfolio III Fund C Inc | 1.24M | 1.70 | 0.81 | 2.73 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 1.93B | 2.71 | 8.70 | 6.92 | ||
TB Evenlode Income B Income | 3.01B | -1.28 | 4.44 | 7.24 | ||
UK Equity Income Fund Institutional | 80.85M | 3.09 | 8.21 | 6.55 | ||
UK Equity Income Fund Retail Income | 123.68M | 3.04 | 7.62 | 5.96 | ||
UK Equity Income Fund Retail Accumu | 104.47M | -2.29 | 6.00 | 5.23 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 8.66 | 10,148.0 | +1.40% | |
Shell | GB00BP6MXD84 | 7.51 | 27.73 | +3.53% | |
HSBC | GB0005405286 | 5.49 | 762.90 | +2.61% | |
Unilever | GB00B10RZP78 | 5.29 | 54.36 | +0.85% | |
Barclays | GB0031348658 | 4.26 | 268.05 | +3.92% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review